Pasithea Therapeutics
KTTA
KTTA
10 hedge funds and large institutions have $662K invested in Pasithea Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $985K → $662K (-$323K)
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$24K | |
| 2 | +$21.8K | |
| 3 | +$19K | |
| 4 |
VF
Virtu Financial
New York
|
+$15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13K |
Top Sellers
| 1 | -$95K | |
| 2 | -$62K | |
| 3 | -$58.8K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$25K |
| 5 |
BlackRock
New York
|
-$13K |